Filter by Last updated date SelectAfterBeforeFrom - To Date End Date This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Results (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Public Statement on Viramune (Nevirapine) - Severe and Life-Threatening Cutaneous and Hepatic Reactions 12 April 2000News Committee for Proprietary Medicinal Products (CPMP) 58th plenary meeting 20 March 2000Press release Committee for veterinary medicinal products: 53rd meeting 9 March 2000Press releaseVeterinary Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 February 2000News Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 February 2000Press release Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 February 2000News Committee for veterinary medicinal products: 52nd meeting 10 February 2000Press releaseVeterinary Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 January 2000News Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 January 2000Press release 3rd meeting of the Committee for Orphan Medicinal Products 19 January 2000Press releaseHumanRare diseases 1 … 366 367 368 369 370 Page 370 of 384 371 372 373 374 … 384
Public Statement on Viramune (Nevirapine) - Severe and Life-Threatening Cutaneous and Hepatic Reactions 12 April 2000News
Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 February 2000News
Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 February 2000Press release
Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 February 2000News
Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 January 2000News
Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 January 2000Press release
3rd meeting of the Committee for Orphan Medicinal Products 19 January 2000Press releaseHumanRare diseases
